Cormedix INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
CorMedix Inc. has acquired a significant stake in Talphera, Inc. and secured exclusive negotiation rights for a potential full acquisition, contingent on clinical trial results.